Trust Collapsing. It’s Time to Rebuild FDA Transparency
Trust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...
Indices rise and fall as growth, inflation, and risk appetite shift; news and expectations reshape valuation baselines and asset flows.
21,301 articlesTrust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...
Target unveils a strategic shift toward daily essentials, anchoring growth on baby items and groceries while earmarki...
June inflation cooled, sparking a rally in crypto markets. Ethereum led the way with a double‑digit gain, while Bitco...
A single cloud ETF has become the dominant vehicle for exposure as cloud stocks swing in 2026, prompting a shift away...
Cantor Fitzgerald partners with Securitize to explore blockchain-native IPO shares, signaling a shift toward real-tim...
Palantir surged on AI optimism, then cooled. This guide breaks down March catalysts, valuation, and practical ways to...
Two popular 2x silver ETFs tumble in 2026 as volatility and decay erode leverage. AGQ and ZSL illustrate why daily re...
Owlet's Q4 2025 results reveal a company balancing growth with a path toward profitability. This article disentangles...
A private Highgrove moment sparks big conversations about money, privacy, and planning. This article breaks down prac...
The Department of Justice has released additional Epstein-related records that include unverified accusations about P...
Investors are turning to ASML to gauge the health of the global chip cycle. This article breaks down the factors like...
Oracle defies the mood of a bruised AI rally, with Jefferies sticking to a buy and highlighting accelerating cloud gr...